Press "Enter" to skip to content

New patent expiration for Almatica drug GRALISE

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Almatica drug GRALISE

Annual Drug Patent Expirations for GRALISE
Annual Drug Patent Expirations for GRALISE

Gralise is a drug marketed by Almatica and is included in one NDA. It is available from two suppliers. There are six patents protecting this drug and one Paragraph IV challenge.

GRALISE drug price trends.

Drug patent litigation for GRALISE.

This drug has thirty-four patent family members in ten countries.

The generic ingredient in GRALISE is gabapentin. Two suppliers are listed for this compound. Additional details are available on the gabapentin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Almatica drug GRALISE
DrugPatentWatch - Make Better Decisions